Comparison of NMOSD patients did not show a difference from controls (42.4% vs 44% p=0.78).Seroprevalence of Hp was similar between MS and MOGAD (p- 0.16) while it was significantly different for both subtypes when compared to NMOSD (Supplementary Table 1). The gene discussed is HP; the disease is myeloid sarcoma.